tp53 mutations in cll: a large retrospective analysis
Published 6 years ago • 434 plays • Length 3:13Download video MP4
Download video MP3
Similar videos
-
2:11
eric recommendations on tp53 mutation classification
-
2:36
current knowledge of the tp53 mutation and its role in cll
-
1:38
the importance of tp53 in cll
-
1:08
cll genomics: p53 mutations and deletions
-
2:02
the prognostic impact of tp53 and ighv status in the era of targeted therapies in cll
-
1:07
testing for ighv and tp53 mutations to guide treatment decisions in cll
-
3:08
recent updates on tp53 mutation in cll
-
0:54
re-testing in cll: fish analysis and tp53 screening
-
34:10
chronic lymphocytic leukemia (cll)
-
5:03
ighv-mutated vs ighv-unmutated cll | what’s the difference?
-
3:46
latest updates in the cll treatment landscape
-
4:31
the impact of high and low burden tp53 mutations on risk and treatment decision in cll
-
2:26
impact of allelic state on os in tp53-mutant aml and hr-mds
-
2:27
the importance of tp53 & ighv testing before treatment initiation in cll
-
1:26
the role of tp53 in cll
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
1:38
the importance of targeting tp53 in aml and agents being explored
-
2:23
significance of eric study in identifying p53 mutants in cll
-
1:54
does tp53-mutated clonal size impact outcomes of cll patients from the murano study?
-
1:57
tolerability and efficacy of magrolimab plus azacitidine in tp53-mutated aml patients
-
2:14
the importance of tp53 testing in cll
-
1:36
the impact of tp53 mutation on treatment approaches in mcl